- Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well tolerated, treatments of cancer and inflammatory lung diseases
- Cantex is led by Stephen Marcus, M.D., and Neil Flanzraich, seasoned drug developers and pharmaceutical executives with stellar track records of developing blockbuster products and extensive transactional experience